Eva Stylianou

623 total citations
12 papers, 411 citations indexed

About

Eva Stylianou is a scholar working on Immunology, Virology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Eva Stylianou has authored 12 papers receiving a total of 411 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 6 papers in Virology and 2 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Eva Stylianou's work include HIV Research and Treatment (6 papers), Immune Cell Function and Interaction (5 papers) and Food Allergy and Anaphylaxis Research (2 papers). Eva Stylianou is often cited by papers focused on HIV Research and Treatment (6 papers), Immune Cell Function and Interaction (5 papers) and Food Allergy and Anaphylaxis Research (2 papers). Eva Stylianou collaborates with scholars based in Norway, United States and Sweden. Eva Stylianou's co-authors include Stig S. Frøland, Fredrik Müller, Pål Aukrust, Pål Aukrust, Dag Kvale, Klaus Bendtzen, Arne Yndestad, Vigdis Bjerkeli, Jan Kristian Damås and Ingvild Nordøy and has published in prestigious journals such as The Journal of Infectious Diseases, Clinical & Experimental Immunology and Cytokine.

In The Last Decade

Eva Stylianou

12 papers receiving 406 citations

Peers

Eva Stylianou
Nicola Mongiardo Italy
Marie‐France Huguet France
Rada Ellegård Sweden
Martine Pape Germany
Gabriele Forcina Italy
David F. Pavlik United States
Hind Hamzeh France
Helen P. Mutimer United States
Aswani Vunnava United States
Thuy Thanh Pham Vietnam
Nicola Mongiardo Italy
Eva Stylianou
Citations per year, relative to Eva Stylianou Eva Stylianou (= 1×) peers Nicola Mongiardo

Countries citing papers authored by Eva Stylianou

Since Specialization
Citations

This map shows the geographic impact of Eva Stylianou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Stylianou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Stylianou more than expected).

Fields of papers citing papers by Eva Stylianou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Stylianou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Stylianou. The network helps show where Eva Stylianou may publish in the future.

Co-authorship network of co-authors of Eva Stylianou

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Stylianou. A scholar is included among the top collaborators of Eva Stylianou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Stylianou. Eva Stylianou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Storaas, Torgeir, et al.. (2021). Covid-19-vaksiner gir økt risiko for anafylaksi. Tidsskrift for Den norske legeforening. 141(4). 2 indexed citations
2.
Namork, Ellen, Eva Stylianou, Kanutte Huse, et al.. (2020). Reduced polyfunctional T cells and increased cellular activation markers in adult allergy patients reporting adverse reactions to food. BMC Immunology. 21(1). 43–43. 3 indexed citations
3.
Alfonso, José Hernán, et al.. (2020). Skin bioengineering in the diagnosis of occupational protein contact dermatitis. Occupational Medicine. 70(4). 282–285. 1 indexed citations
4.
Alfonso, José Hernán, et al.. (2019). Arbeidsrelatert håndeksem. Tidsskrift for Den norske legeforening. 139(10). 3 indexed citations
5.
Stylianou, Eva, Thor Ueland, Annika E. Michelsen, et al.. (2016). Specific allergen immunotherapy: effect on IgE, IgG4 and chemokines in patients with allergic rhinitis. Scandinavian Journal of Clinical and Laboratory Investigation. 76(2). 118–127. 14 indexed citations
6.
Jensenius, Mogens, Thor Ueland, Pierre‐Edouard Fournier, et al.. (2003). Systemic Inflammatory Responses in African Tick‐Bite Fever. The Journal of Infectious Diseases. 187(8). 1332–1336. 24 indexed citations
7.
Stylianou, Eva, Vigdis Bjerkeli, Arne Yndestad, et al.. (2003). Raised serum levels of interleukin-18 is associated with disease progression and may contribute to virological treatment failure in HIV-1-infected patients. Clinical & Experimental Immunology. 132(3). 462–466. 46 indexed citations
8.
Stylianou, Eva, Arne Yndestad, Liv Ingunn Bjoner Sikkeland, et al.. (2002). Effects of interferon-αon gene expression of chemokines and members of the tumour necrosis factor superfamily in HIV-infected patients. Clinical & Experimental Immunology. 130(2). 279–285. 28 indexed citations
9.
Stylianou, Eva, Pål Aukrust, Fredrik Müller, Ingvild Nordøy, & Stig S. Frøland. (2001). COMPLEX EFFECTS OF INTERFERON-α ON THE CYTOKINE NETWORK IN HIV INFECTION—POSSIBLE CONTRIBUTION TO IMMUNOSUPPRESSION. Cytokine. 14(1). 56–62. 28 indexed citations
10.
Stylianou, Eva, Pål Aukrust, Ingvild Nordøy, Fredrik Müller, & Stig S. Frøland. (2000). Enhancement of lymphocyte proliferation induced by interleukin‐12 and anti‐interleukin‐10 in HIV‐infected patients during highly active antiretroviral therapy. Apmis. 108(9). 601–607. 5 indexed citations
11.
Stylianou, Eva, Pål Aukrust, Klaus Bendtzen, Fredrik Müller, & Stig S. Frøland. (2000). Interferons and interferon (IFN)-inducible protein 10 during highly active anti-retroviral therapy (HAART)—possible immunosuppressive role of IFN-α in HIV infection. Clinical & Experimental Immunology. 119(3). 479–485. 94 indexed citations
12.
Stylianou, Eva, Pål Aukrust, Dag Kvale, Fredrik Müller, & Stig S. Frøland. (1999). IL-10 in HIV infection: increasing serum IL-10 levels with disease progression—down-regulatory effect of potent anti-retroviral therapy. Clinical & Experimental Immunology. 116(1). 115–120. 163 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicola Mongiardo Breakdown of academic impact, for papers by Marie‐France Huguet Breakdown of academic impact, for papers by Rada Ellegård Breakdown of academic impact, for papers by Martine Pape Breakdown of academic impact, for papers by Gabriele Forcina Breakdown of academic impact, for papers by David F. Pavlik Breakdown of academic impact, for papers by Hind Hamzeh Breakdown of academic impact, for papers by Helen P. Mutimer Breakdown of academic impact, for papers by Aswani Vunnava Breakdown of academic impact, for papers by Thuy Thanh Pham
Rankless by CCL
2026